Abstract
Purpose
Tumors can be visualized using 5-Aminolevulinic acid hydrochloride (5-ALA) during transurethral resection of bladder tumors (TURBT). Hypotension is an adverse effect of 5-ALA; however, its incidence and morbidity rates are unknown. This study aimed to describe the incidence of perioperative hypotension and identify risk factors for hypotension among patients after 5-ALA administration in TURBT.
Methods
This retrospective multicenter cohort study was conducted at three general hospitals in Japan. Adult patients who underwent elective TURBT after 5-ALA administration between April 2018 and August 2020 were included. The primary outcome was the incidence of perioperative hypotension (mean blood pressure < 65 mmHg). The secondary outcomes were the use of vasoactive agents and adverse events, including urgent intensive care unit (ICU) admission. Multivariate logistic regression analysis was performed to investigate risk factors of the incidence of intraoperative hypotension.
Results
The median age of 261 patients was 73 years. General anesthesia was induced in 252 patients. The intraoperative hypotension was observed in 246 (94.3%) patients. Three patients (1.1%) were urgently admitted to the ICU for continued vasoactive agent use after surgery. All three patients had renal dysfunction. Multivariate logistic regression analysis revealed that general anesthesia was significantly associated with intraoperative hypotension (adjusted odds ratio, 17.94; 95% confidence interval, 3.21–100.81).
Conclusion
The incidence of hypotension in patients undergoing TURBT after 5-ALA administration was 94.3%. The incidence of urgent ICU admission with prolonged hypotension was 1.1% in all patients with renal dysfunction. General anesthesia was significantly associated with intraoperative hypotension.
Similar content being viewed by others
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a randomized, double-blind, multicentre phase II/III study. Photodiagnosis Photodyn Ther. 2015;12:193–200. https://doi.org/10.1016/j.pdpdt.2015.03.008.
Nakai Y, Inoue K, Tsuzuki T, Shimamoto T, Shuin T, Nagao K, Matsuyama H, Oyama M, Furuse H, Ozono S, Miyake M, Fujimoto K. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a multicenter phase III study. Int J Urol. 2018;25:723–9. https://doi.org/10.1111/iju.13718.
Kida T, Kobashi T, Usuda Y, Kobayashi K, Sumitomo M. Severe and prolonged hypotension after oral 5-aminolevulinic acid administration in a patient with end-stage renal disease undergoing transurethral resection of a bladder tumor: a case report. A A Pract. 2020;14:12–4. https://doi.org/10.1213/xaa.0000000000001128.
Shiratori T, Hotta K, Satoh M, Kiuchi C, Ogawa N, Kamigaito T. Preanesthetic severe postural hypotension following 5-aminolevulinic acid pretreatment in patients for photodynamic diagnosis-assisted urological surgery. JA Clin Rep. 2019;5:74. https://doi.org/10.1186/s40981-019-0295-1.
Yatabe T, Marie SL, Fukuhara H, Karashima T, Inoue K, Yokoyama M. 5-Aminolevulinic acid-induced severe hypotension during transurethral resection of a bladder tumor: a case report. JA Clin Rep. 2019;5:58. https://doi.org/10.1186/s40981-019-0279-1.
Chung IW, Eljamel S. Risk factors for developing oral 5-aminolevulinic acid-induced side effects in patients undergoing fluorescence guided resection. Photodiagnosis Photodyn Ther. 2013;10:362–7. https://doi.org/10.1016/j.pdpdt.2013.03.007.
Yatabe T, Karashima T, Kume M, Kawanishi Y, Fukuhara H, Ueba T, Inoue K, Okuhara Y, Yokoyama M. Identification of risk factors for post-induction hypotension in patients receiving 5-aminolevulinic acid: a single-center retrospective study. JA Clin Rep. 2020;6:35. https://doi.org/10.1186/s40981-020-00340-9.
Sessler DI, Bloomstone JA, Aronson S, Berry C, Gan TJ, Kellum JA, Plumb J, Mythen MG, Grocott MPW, Edwards MR, Miller TE. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;122:563–74. https://doi.org/10.1016/j.bja.2019.01.013.
Kidney Disease: Improving Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):1–150. https://doi.org/10.1038/kisup.2012.64.
Nohara T, Kato Y, Nakano T, Nakagawa T, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Shigehara K, Izumi K, Kadono Y, Mizokami A. Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer. Int J Urol. 2019;26:1064–8. https://doi.org/10.1111/iju.14099.
Fukuhara H, Nohara T, Nishimoto K, Hatakeyama Y, Hyodo Y, Okuhara Y, Oyama M, Mizokami A, Inoue K, Matsuyama H. Japan Urological Photodynamic Society Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study. BMC Cancer. 2021;21:1223. https://doi.org/10.1186/s12885-021-08976-1.
Mingone CJ, Gupte SA, Chow JL, Ahmad M, Abraham NG, Wolin MS. Protoporphyrin IX generation from delta-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation. Am J Physiol Lung Cell Mol Physiol. 2006;291:L337–44. https://doi.org/10.1152/ajplung.00482.2005.
Eichhorn V, Maerz A, Salomon G, Blanc IF, Reuter DA, Goetz AE. Hemodynamic effects of orally administered delta-ALA during radical prostatectomy. World J Urol. 2013;31:371–6. https://doi.org/10.1007/s00345-011-0788-7.
Sato M, Yanagisawa T, Minamino S, Arai T. Hypotension caused by oral administration of 5-aminolevulinic acid persists after surgery in patients undergoing transurethral resection of bladder tumor under spinal anesthesia. JA Clin Rep. 2020;6:93. https://doi.org/10.1186/s40981-020-00399-4.
Miyakawa J, Kawai T, Makino K, Akiyama Y, Yamada Y, Nakamura M, Sato Y, Yamada D, Suzuki M, Kume H. Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor. Photodiagnosis Photodyn Ther. 2021;33:102179. https://doi.org/10.1016/j.pdpdt.2021.102179.
Dalton JT, Yates CR, Yin D, Straughn A, Marcus SL, Golub AL, Meyer MC. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer. J Pharmacol Exp Ther. 2002;301:507–12. https://doi.org/10.1124/jpet.301.2.507.
Gorchein A, Webber R. delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects. Clin Sci (Lond). 1987;72:103–12. https://doi.org/10.1042/cs0720103.
Funding
The study did not receive funding from any company or organization.
Author information
Authors and Affiliations
Contributions
Conceptualization: YK, YN. Investigation: YK, NY, TK, MY. Methodology: YK, YN. Project administration: YK, NE, TK, MS, MY, GI. Supervision: YN, TG. Visualization: YK. Writing–original draft: YK. Writing–review and editing: YN, NY, NE, TK, MS, MY, GI, TG. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
This study was approved by the ethics committee of the Yokohama Rosai Hospital, the core institution (approval number: 2–26; chairperson: Dr. Youji Mikami; approval date: August 24, 2020), and by the ethics committees of the participating institutions (Yokohama Municipal Citizen’s Hospital [approval number: 20–10-02; chairperson: Dr. Akihiro Nakazawa; approval date: October 14, 2020] and Yokosuka Kyosai Hospital [approval number: 20–57; chairperson: Dr. Takashi Irioka; approval date: September 29, 2020]). The requirement of informed consent was waived by the ethics committees (Yokohama Rosai Hospital, Yokohama Municipal Citizen’s Hospital, and Yokosuka Kyosai Hospital). The opportunity to withdraw consent was indicated by a notice on the website of each facility. All methods were carried out in accordance with the Declaration of Helsinki.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kondo, Y., Nagamine, Y., Yoshikawa, N. et al. Incidence of perioperative hypotension in patients undergoing transurethral resection of bladder tumor after oral 5-aminolevulinic acid administration: a retrospective multicenter cohort study. J Anesth 37, 703–713 (2023). https://doi.org/10.1007/s00540-023-03222-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-023-03222-3